Reward pathways in Parkinson's disease: Clinical and theoretical implications
- 14 April 2008
- journal article
- review article
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 62 (2) , 203-213
Abstract
Aims: The mesolimbic and mesocortical circuits are particularly involved in reward‐related behavior in humans. Because these systems may be in some way altered in Parkinson's disease (PD), it is likely that some psychiatric manifestations of PD, such as hedonistic homeostatic dysregulation and pathological gambling, as well as impulsive decision making, may be ascribed to their involvement. The aim of the current article was to review recent literature on this topic in order to analyze whether these disturbances share a common ground and whether actual theoretical frameworks on addiction prove a useful tool for their interpretation.Methods: Data were identified on searches of MEDLINE/PubMed databases from relevant articles published up until March 2007.Results: All clinical manifestations (hedonistic homeostatic dysregulation, pathological gambling and impulsive decision making) seem to share a common multifaceted ground in which factors related to antiparkinsonian therapy, premorbid personality and progression of disease interact. Theoretical interpretations and conclusions drawn from experimental studies may help to shed light on the underlying pathological mechanisms.Conclusions: Further studies are needed to analyze why, despite a common ground, only some patients develop those neuropsychiatric complications described here.Keywords
This publication has 94 references indexed in Scilit:
- Amisulpride in the short-term treatment of depressive and physical symptoms in cancer patients during chemotherapiesSupportive Care in Cancer, 2007
- Association of Dopamine Agonist Use With Impulse Control Disorders in Parkinson DiseaseArchives of Neurology, 2006
- Orbitofrontal cortex, decision-making and drug addictionTrends in Neurosciences, 2006
- Chemistry of the mind: Neurochemical modulation of prefrontal cortical functionJournal of Comparative Neurology, 2005
- Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspectiveNature Neuroscience, 2005
- Physical anhedonia in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Allelic variation of serotonin transporter expression is associated with depression in Parkinson's diseaseMolecular Psychiatry, 2001
- Drug Addiction, Dysregulation of Reward, and AllostasisNeuropsychopharmacology, 2001
- NEUROBIOLOGICAL CONSTRAINTS ON BEHAVIORAL MODELS OF MOTIVATIONAnnual Review of Psychology, 1997
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988